Where is the live CopyMark page for USPTO serial 79094745?

The live record is at https://getcopymark.com/trademark/79094745. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns RHEOSORBILACT?

According to the public USPTO record for serial number 79094745, the listed owner(s) include: Association limited "Medical center "M.T.K."", Association limited "Medical center "M.T.K."", Association limited "Medical center "M.T.K."".

What is USPTO serial number 79094745?

Serial number 79094745 is the USPTO application identifier for the mark RHEOSORBILACT. It is used to track examination, publication, and registration of this trademark.

What is the current status of RHEOSORBILACT?

RHEOSORBILACT (79094745) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover RHEOSORBILACT?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: RHEOSORBILACT Serial# 79094745 | status 404; last event DENC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RHEOSORBILACT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for improving capillary circulation, for prevention and treatment of traumatic, operative, hemolytic, toxic and burn shock, acute blood losses, burn disease, for prevention and treatment of intoxication caused by contagious diseases, aggravation of chronic hepatitis, sepsis, for prevention and treatment of dehydration, for prevention and treatment of water-electrolyte imbalance during pre-operative and post-operative periods, for improving arterial and venous circulation to prevent thrombosis, thrombophlebitis, endarteritis, Raynaud Syndrome; vaccines; vitamin preparations; medicinal cosmetics	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Aug 28, 2021	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Aug 28, 2021	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Sep 27, 2019	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Jun 28, 2019	XXSS	GENERIC MADRID TRANSACTION SENT TO IB	—
Jun 28, 2019	XXCR	GENERIC MADRID TRANSACTION CREATED	—
Jun 12, 2019	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Oct 12, 2018	C71T	CANCELLED SECTION 71	—
Oct 14, 2012	GPNX	NOTIFICATION PROCESSED BY IB	—
Sep 29, 2012	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Sep 12, 2012	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Sep 12, 2012	FIMP	FINAL DISPOSITION PROCESSED	—
Jun 6, 2012	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Mar 6, 2012	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 20, 2011	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 30, 2011	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Nov 30, 2011	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Nov 30, 2011	NPUB	NOTICE OF PUBLICATION	—
Nov 15, 2011	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Nov 10, 2011	ALIE	ASSIGNED TO LIE	—
Nov 3, 2011	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 28, 2011	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Oct 28, 2011	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 28, 2011	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 4, 2011	RFNP	REFUSAL PROCESSED BY IB	—
May 17, 2011	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
May 17, 2011	RFRR	REFUSAL PROCESSED BY MPU	—
May 14, 2011	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
May 13, 2011	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2011	DOCK	ASSIGNED TO EXAMINER	—
Apr 8, 2011	MAFR	APPLICATION FILING RECEIPT MAILED	—
Apr 4, 2011	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Mar 31, 2011	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

RHEOSORBILACT